Hormone replacement treatment and breast cancer risk: a cooperative Italian study.

por La Vecchia, C., Negri, E., Franceschi, S., Favero, A., Nanni, O., Filiberti, R., Conti, E., Montella, M., Veronesi, A., Ferraroni, M.
Publicado 1995

Activity of endovesical gemcitabine in BCG-refractory bladder cancer patients: a translational study

por Gunelli, R, Bercovich, E, Nanni, O, Ballardini, M, Frassineti, G L, Giovannini, N, Fiori, M, Pasquini, E, Ulivi, P, Pappagallo, G L, Silvestrini, R, Zoli, W
Publicado 2007

Role of biological markers in the clinical outcome of colon cancer

por Nanni, O, Volpi, A, Frassineti, G L, De Paola, F, Granato, A M, Dubini, A, Zoli, W, Scarpi, E, Turci, D, Oliverio, G, Gambi, A, Amadori, D
Publicado 2002

Delayed infection, late tonsillectomy or adenoidectomy and adult leukaemia: a case–control study

por Vineis, P, Miligi, L, Crosignani, P, Davico, L, Fontana, A, Masala, G, Nanni, O, Ramazzotti, V, Rodella, S, Stagnaro, E, Tumino, R, Viganò, C, Vindigni, C, Costantini, A S
Publicado 2003

Phase II study of capecitabine-based concomitant chemoradiation followed by durvalumab as a neoadjuvant strategy in locally advanced rectal cancer: the PANDORA trial

por Grassi, E., Zingaretti, C., Petracci, E., Corbelli, J., Papiani, G., Banchelli, I., Valli, I., Frassineti, G.L., Passardi, A., Di Bartolomeo, M., Pietrantonio, F., Gelsomino, F., Carandina, I., Banzi, M., Martella, L., Bonetti, A.V., Boccaccino, A., Molinari, C., Marisi, G., Ugolini, G., Nanni, O., Tamberi, S.
Publicado 2023